| Literature DB >> 25608760 |
Rodolphe Bourret1,2, Grégoire Mercier3,4, Jacques Mercier5,6,7, Olivier Jonquet8,9,10, Jean-Emmanuel De La Coussaye11,12,13, Philippe J Bousquet14, Jean-Marie Robine15,16, Jean Bousquet17,18,19.
Abstract
BACKGROUND: Potentially avoidable hospitalizations represent an indirect measure of access to effective primary care. However many approaches have been proposed to measure them and results may differ considerably. This work aimed at examining the agreement between the Weissman and Ansari approaches in order to measure potentially avoidable hospitalizations in France.Entities:
Mesh:
Year: 2015 PMID: 25608760 PMCID: PMC4316643 DOI: 10.1186/s12913-014-0661-7
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
PAH selection algorithm according to Weissman et al. modified by Gusmano et al.
|
|
|
|---|---|
| Bacterial pneumonia | J13, J14, J15, J16.0, J16.8, J18 |
| Congestive heart failure | I50 |
| Asthma | J45 |
| Cellulitis | J34.0, K12.2, L02, L03 |
| Complications of peptic ulcer disease | K25.0, K25.1, K25.2, K25.4, K25.5, K25.6, K26.0, K26.1, K26.2, K26.4, K26.5, K26.6, K27.0, K27.1, K27.2, K27.4, K27.5, K27.6, K28.0, K28.1, K28.2, K28.4, K28.5, K28.6 |
| Pyelonephritis | N10, N11, N12, N13.6, N15.8, N15.9, N17.2 |
| Type 2 diabetes mellitus with hyperosmolarity or coma | E10.0, E10.1, E11.0, E11.1, E13.0, E13.1, E14.0, E14.1 |
| Ruptured appendix | K35.2, K35.3 |
| Hypertension | I10, I11.0, I11.9, I12.0, I12.9, I13.0, I13.1, I13.2, I13.9, I15.0, |
| Hypokalaemia | E87.6 |
| Immunizable conditions | A35, A36, A37, A80, B05, B26 |
| Gangrene | I73.0, L88, I70.2 |
PAH selection algorithm according to Ansari et al.
|
|
|
|
|---|---|---|
| Influenza and pneumonia | J10, J11, J13, J14, J15.3, J15.4, J15.7, J15.9, J16.8, J18.1, J18.8 | In any diagnosis field, exclude cases with secondary diagnosis of D57, and people under 2 months |
| Other vaccine preventable | A35, A36, A37, A80, B05, B06, B16.1, B16.9, B18.0, B18.1, B26, G00.0, M01.4 | In any diagnosis field |
| Asthma | J45, J46 | Principal diagnosis only |
| Congestive heart failure | I50, I11.0, J81 | Principal diagnosis only, exclude cases with procedure codes |
| Diabetes complications | E10.1, E10.2, E10.3, E10.4, E10.5, E10.6, E10.7, E10.8, E11.0, E11.1, E11.2, E11.3, E11.4, E11.5, E11.6, E11.7, E11.8, E13.0, E13.1, E13.2, E13.3, E13.4, E13.5, E13.6, E13.7, E13.8, E14.0, E14.1, E14.2, E14.3, E14.4, E14.5, E14.6, E14.7, E14.8 | In any diagnosis field |
| Chronic obstructive pulmonary disease | J20, J41, J42, J43, J44, J47 | Principal diagnosis only, J20 only with diag2 of J41 J42 J43 J47 J44 |
| Angina | I20, I24.0, I24.8, I24.9 | Principal diagnosis only, exclude cases with procedure codes |
| Iron deficiency anaemia | D50.1, D50.8, D50.9 | Principal diagnosis only |
| Hypertension | I10, I11.9 | Principal diagnosis only, exclude cases with procedure codes |
| Nutritional deficiencies | E40, E41, E42, E43, E55.0, E64.3 | Principal diagnosis only |
| Dehydration and gastroenteritis | E86, K52.2, K52.8, K52.9 | Principal diagnosis only |
| Pyelonephritis | N39.0, N10, N12, N11, N13.6 | Principal diagnosis only |
| Perforated/ bleeding ulcer | K25.0, K25.1, K25.2, K25.4, K25.5, K25.6, K26.0, K26.1, K26.2, K26.4, K26.5, K26.6, K27.0, K27.1, K27.2, K27.4, K27.5, K27.6, K28.0, K28.1, K28.2, K28.4, K28.5, K28.6 | Principal diagnosis only |
| Cellulitis | L03, L04, L08, L98.0, L88, L98.3 | Principal diagnosis only, exclude cases with procedure codes |
| Pelvic inflammatory disease | N70, N73, N74 | Principal diagnosis only |
| Ear, nose and throat infections | H66, H67, J02, J03, J06, J31.2 | Principal diagnosis only |
| Dental conditions | K02, K03, K04, K05, K06, K08, K09.8, K09.9, K12, K13 | Principal diagnosis only |
| Convulsions and epilepsy | O15, G40, G41, R56 | Principal diagnosis only |
| Gangrene | R02 | Principal diagnosis only |
Number of PAH in France in 2012 according to severity, type of event and diagnosis-related groups
|
|
|
| ||
|---|---|---|---|---|
|
|
| |||
| Diagnosis | 1 (nervous system) | 6,724 (1.3%) | 455 (0.1%) | <.001 |
| group | 2 (eye) | 106 (0.0%) | NA | . |
| 3 (ENT) | 956 (0.2%) | 5,262 (0.7%) | . | |
| 4 (respiratory system) | 211,490 (41.5%) | 229,314 (30.9%) | . | |
| 5 (circulatory system) | 252,883 (49.6%) | 288,396 (38.8%) | . | |
| 6 (digestive system) | 4,671 (0.9%) | 50,947 (6.9%) | . | |
| 7 (liver and pancreas) | 1,927 (0.4%) | NA | . | |
| 8 (musculoskeletal system) | 3,423 (0.7%) | NA | . | |
| 9 (skin) | 6,568 (1.3%) | 65,787 (8.9%) | . | |
| 10 (endocrine and nutritional) | 2,612 (0.5%) | 20,807 (2.8%) | . | |
| 11 (urinary system) | 3,786 (0.7%) | 79,428 (10.7%) | . | |
| 12 (genital, male) | 331 (0.1%) | 4 (0.0%) | . | |
| 13 (genital, female) | 165 (0.0%) | NA | . | |
| 14 (obstetrics) | 407 (0.1%) | NA | . | |
| 15 (childbirth) | 143 (0.0%) | 95 (0.0%) | . | |
| 16 (haematology) | 2,607 (0.5%) | NA | . | |
| 17 (haematology, others) | 1,319 (0.3%) | NA | . | |
| 18 (infectious diseases) | 2,125 (0.4%) | 301 (0.0%) | . | |
| 19 (psychiatry) | 1,147 (0.2%) | NA | . | |
| 20 (psychiatry, organic) | 329 (0.1%) | NA | . | |
| 21 (external causes) | 754 (0.2%) | NA | . | |
| 22 (burns) | 142 (0.0%) | NA | . | |
| 23 (other) | 3,092 (0.6%) | NA | ||
| 25 (HIV) | 1,040 (0.2%) | 1,521 (0.2%) | . | |
| 26 (polytrauma) | 431 (0.1%) | NA | ||
| 27 (transplantations) | 415 (0.1%) | 157 (0.0%) | ||
| 28 (very short stays) | 613 (0.1%) | 0 | ||
| Type | Surgical procedure | 16,002 (3.1%) | 98,545 (13.3%) | <.001 |
| Non-surgical procedure | 24,753 (4.9%) | 50,899 (6.9%) | . | |
| Medical stay | 466,249 (91.4%) | 592,961 (79.9%) | . | |
| Short stays | 3,202 (0.6%) | 69 (0.0%) | ||
| Severity | 1 (low) | 107,578 (21.1%) | 229,912 (31.0%) | <.001 |
| 2 | 150,140 (29.4%) | 164,501 (22.2%) | . | |
| 3 | 143,854 (28.2%) | 174,614 (23.5%) | . | |
| 4 (high) | 34,814 (6.8%) | 37,813 (5.1%) | ||
| Sex | Male | 269,771 (52.9%) | 370,053 (49.8%) | <.001 |
| Female | 240,435 (47.1%) | 372,421 (50.16%) | . | |
| Age (yrs) | (mean, SD) | 72 (20) | 61 (29) | <.001 |
| 0-17 yr | 21,142 (4.1%) | 100,629 (13.6%) | <.001 | |
| 18-64 yr | 111,164 (21.8%) | 214,170 (28.9%) | ||
| 65-74 yr | 78,589 (15.4%) | 90,402 (12.2%) | ||
| ≥75. yr | 299,311 (58.7%) | 337,273 (45.4%) | ||
| Length of stay (days) | (mean, SD) | 9.6 (11.5) | 7.3 (8.5) | <.001 |
Figure 1Maps of standardised rate of PAH in French departments, 2012.
Figure 2Correlation between standardised rates of PAH in France in 2012. Legend: Figure 2 shows the correlation between age and sex-standardised rates of PAH measured by the Weissman and Ansari approaches. Each dot represents a department.